Resultats de la cerca - Marija Trajkovic‐Arsic

  • Mostrar 1 - 16 resultats de 16
Refinar resultats
  1. 1
    The role of insulin and IGF system in pancreatic cancer

    The role of insulin and IGF system in pancreatic cancer per Marija Trajkovic‐Arsic, Evdokia Kalideris, Jens T. Siveke

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Tetrac Can Replace Thyroid Hormone During Brain Development in Mouse Mutants Deficient in the Thyroid Hormone Transporter Mct8

    Tetrac Can Replace Thyroid Hormone During Brain Development in Mouse Mutants Deficient in the Thyroid Hormone Transporter Mct8 per Sigrun Horn, Simone Kersseboom, Steffen Mayerl, Julia Müller, Claudia Groba, Marija Trajkovic‐Arsic, Tobias Ackermann, Theo J. Visser, Heike Heuer

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Equivalent tumor detection for early and late FAPI-46 PET acquisition

    Equivalent tumor detection for early and late FAPI-46 PET acquisition per Justin Ferdinandus, Lukas Kessler, Nader Hirmas, Marija Trajkovic‐Arsic, Rainer Hamacher, Lale Umutlu, Michael Nader, Fadi Zarrad, Manuel Weber, Wolfgang P. Fendler

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    MALDI Imaging Mass Spectrometry for In Situ Proteomic Analysis of Preneoplastic Lesions in Pancreatic Cancer

    MALDI Imaging Mass Spectrometry for In Situ Proteomic Analysis of Preneoplastic Lesions in Pancreatic Cancer per Barbara M. Grüner, Hannes Hahne, Paweł K. Mazur, Marija Trajkovic‐Arsic, Stefan A. Maier, Iréne Esposito, Evdokia Kalideris, Christoph Michalski, Jörg Kleeff, Sandra Rauser, Roland M. Schmid, Bernhard Küster, Axel Walch, Jens T. Siveke

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Co-clinical Assessment of Tumor Cellularity in Pancreatic Cancer

    Co-clinical Assessment of Tumor Cellularity in Pancreatic Cancer per Irina Heid, Katja Steiger, Marija Trajkovic‐Arsic, Marcus Settles, Manuela R. Eßwein, Mert Erkan, Jörg Kleeff, Carsten Jäger, Helmut Friess, Bernhard Haller, Andreas Steingötter, Roland M. Schmid, Markus Schwaiger, Ernst J. Rummeny, Iréne Esposito, Jens T. Siveke, Rickmer Braren

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinoma

    PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinoma per Ben Zhao, Rui Fang, Hendrik Schürmann, Erik Jan Hemmer, Gina Lauren Mayer, Marija Trajkovic-Arsic, Kristina Althoff, Jiajin Yang, Laura Godfrey, Sven T. Liffers, Konstantinos Savvatakis, Madeleine Dorsch, Barbara M. Grüner, Stephan A. Hahn, Marc Remke, Smiths Lueong, Jens T. Siveke

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Multimodal Molecular Imaging of Integrin α<sub>v</sub>β<sub>3</sub> for In Vivo Detection of Pancreatic Cancer

    Multimodal Molecular Imaging of Integrin α<sub>v</sub>β<sub>3</sub> for In Vivo Detection of Pancreatic Cancer per Marija Trajkovic‐Arsic, Pouyan Mohajerani, Athanasios Sarantopoulos, Evdokia Kalideris, Katja Steiger, Iréne Esposito, Xiaopeng Ma, George Themelis, Neal C. Burton, Christoph Michalski, Jörg Kleeff, Stefan Stangl, Ambros J. Beer, Karolin Pohle, Hans‐Jürgen Wester, Roland M. Schmid, Rickmer Braren, Vasilis Ntziachristos, Jens T. Siveke

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Characterization of a dual <scp>BET</scp>/<scp>HDAC</scp> inhibitor for treatment of pancreatic ductal adenocarcinoma

    Characterization of a dual <scp>BET</scp>/<scp>HDAC</scp> inhibitor for treatment of pancreatic ductal adenocarcinoma per Xin Zhang, Tim Zegar, Tim Weiser, Feda H. Hamdan, Benedict‐Tilman Berger, Romain Lucas, Dimitrios-Ilias Balourdas, Swetlana Ladigan, Phyllis F. Cheung, Sven‐Thorsten Liffers, Marija Trajkovic‐Arsic, Björn Scheffler, Andreas C. Joerger, Stephan A. Hahn, Steven A. Johnsen, Stefan Knapp, Jens T. Siveke

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation

    Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation per Laura Godfrey, Jan Förster, Sven‐Thorsten Liffers, Christopher Schröder, Johannes Köster, Leonie Henschel, Kerstin U. Ludwig, David Lähnemann, Marija Trajkovic‐Arsic, Diana Behrens, Aldo Scarpa, Rita T. Lawlor, Kathrin E. Witzke, Barbara Sitek, Steven A. Johnsen, Sven Rahmann, Bernhard Horsthemke, Michael Zeschnigk, Jens T. Siveke

    Publicat 2024
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth

    LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth per Oihane Erice, Shruthi Narayanan, Iker Feliu, Rodrigo Entrialgo‐Cadierno, Antonia Malinova, Caterina Vicentini, Elizabeth Guruceaga, Pietro Delfino, Marija Trajkovic‐Arsic, Haritz Moreno, Karmele Valencia, Ester Blanco, Irati Macaya, Daniel Öhlund, Purvesh Khatri, Fernando Lecanda, Aldo Scarpa, Jens T. Siveke, Vincenzo Corbo, Mariano Ponz‐Sarvisé, Silvestre Vicent

    Publicat 2023
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Superior Tumor Detection for<sup>68</sup>Ga-FAPI-46 Versus<sup>18</sup>F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma

    Superior Tumor Detection for<sup>68</sup>Ga-FAPI-46 Versus<sup>18</sup>F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma per Kim M. Pabst, Marija Trajkovic‐Arsic, Phyllis F. Cheung, Simone Ballke, Katja Steiger, Timo Bartel, Benedikt M. Schaarschmidt, Aleksandar Milošević, Robert Seifert, Michael A. Nader, Lukas Kessler, Jens T. Siveke, Katharina Lueckerath, Stefan Kasper, Ken Herrmann, Nader Hirmas, Hartmut Schmidt, Rainer Hamacher, Wolfgang P. Fendler

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis

    EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis per Christine Ardito-Abraham, Barbara M. Grüner, Kenneth K. Takeuchi, Clara Lubeseder–Martellato, Nicole Teichmann, Paweł K. Mazur, Kathleen E. DelGiorno, Eileen S. Carpenter, Christopher J. Halbrook, Jason C. Hall, Debjani Pal, Thomas von Briel, Alexander Herner, Marija Trajkovic‐Arsic, Bence Sipos, Geou‐Yarh Liou, Peter Störz, Nicole R. Murray, David W. Threadgill, Maria Sibilia, M. Kay Washington, Carole L. Wilson, R Schmid, Elaine W. Raines, Howard C. Crawford, Jens T. Siveke

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer

    Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer per Joseph Tintelnot, Yang Xu, Till Robin Lesker, Martin Schönlein, Leonie Konczalla, Anastasios D. Giannou, Penelope Pelczar, Dominik Kylies, Victor G. Puelles, Agata A. Bielecka, Manuela Peschka, Filippo Cortesi, Kristoffer Riecken, Maximilian Jung, Lena Amend, Tobias Sebastian Bröring, Marija Trajkovic‐Arsic, Jens T. Siveke, Thomas Renné, Danmei Zhang, Stefan Boeck, Till Strowig, Faik G. Uzunoǧlu, Cenap Güngör, Alexander Stein, Jakob R. Izbicki, Carsten Bokemeyer, Marianne Sinn, Alec C. Kimmelman, Samuel Huber, Nicola Gagliani

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma

    Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma per Paweł K. Mazur, Alexander Herner, Stephano S. Mello, Matthias Wirth, Simone Hausmann, Francisco J. Sánchez‐Rivera, Shane Lofgren, Timo Kuschma, Stephan A. Hahn, Deepak Vangala, Marija Trajkovic‐Arsic, Aayush Gupta, Irina Heid, Peter B. Noël, Rickmer Braren, Mert Erkan, Jörg Kleeff, Bence Sipos, Leanne C. Sayles, Mathias Heikenwälder, Elisabeth Heßmann, Volker Ellenrieder, Iréne Esposito, Tyler Jacks, James E. Bradner, Purvesh Khatri, E. Alejandro Sweet‐Cordero, Laura D. Attardi, Roland M. Schmid, Guenter Schneider, Julien Sage, Jens T. Siveke

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma

    The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma per Ulvi Ahmadov, Daniel Picard, Jasmin Bartl, Manuela Silginer, Marija Trajkovic‐Arsic, Nan Qin, Lena Blümel, Marietta Wolter, Jonathan Lim, David Pauck, Alina M. Winkelkotte, Marlen Melcher, Maike Langini, Viktoria Marquardt, Felix Sander, Anja Stefanski, Sascha Steltgens, Christina Hassiepen, Anna Kaufhold, Frauke-Dorothee Meyer, Annette Seibt, Lara Kleinesudeik, Anika Hain, Carsten Münk, Christiane B. Knobbe‐Thomsen, Alexander Schramm, Ute Fischer, Gabriel Leprivier, Kai Stühler, Simone Fulda, Jens T. Siveke, Felix Distelmaier, Arndt Borkhardt, Michael Weller, Patrick Roth, Guido Reifenberger, Marc Remke

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I

    MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I per Johannes Brägelmann, Carina Lorenz, Sven Borchmann, Kazuya Nishii, Julia Wegner, Lydia Meder, Jenny Ostendorp, David Ast, Alena Heimsoeth, Takamasa Nakasuka, Atsuko Hirabae, Sachi Okawa, Marcel A. Dammert, Dennis Plenker, Sebastian Klein, Philipp Lohneis, Jianing Gu, Laura Godfrey, Jan Förster, Marija Trajkovic‐Arsic, Thomas Zillinger, Mareike Haarmann, Alexander Quaas, S Lennartz, Marcel Schmiel, Joshua D’Rozario, Emily Thomas, Henry Li, Clemens A. Schmitt, Julie George, Roman K. Thomas, Silvia von Karstedt, Gunther Hartmann, Reinhard Büttner, Roland T. Ullrich, Jens T. Siveke, Kadoaki Ohashi, Martin Schlee, Martin L. Sos

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: